Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Scheiblhofer

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Vaccine|August 20, 2013
The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccineEsther E Weinberger, Almedina Isakovic, Sandra Scheiblhofer, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Strategies for the development of safe and effective DNA vaccines for allergy treatmentArnulf Hartl, Richard Weiss, Romana Hochreiter, et al.
The Journal of Allergy and Clinical Immunology|August 12, 2009
Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergensElisabeth Roesler, Richard Weiss, Esther E Weinberger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 14, 2012
Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: a novel tool for specific immunotherapyEsther E Weinberger, Martin Himly, Julia Myschik, et al.
International Archives of Allergy and Immunology|April 5, 2012
T cell epitopes of the timothy grass pollen allergen Phl p 5 of mice and men and the detection of allergen-specific T cells using Class II UltimersAngelika Stoecklinger, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Allergy|December 28, 2019
Laser-facilitated epicutaneous immunotherapy with depigmented house dust mite extract alleviates allergic responses in a mouse model of allergic lung inflammationEvgeniia Korotchenko, Raquel Moya, Sandra Scheiblhofer, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|November 19, 2003
Treatment of 1-methyl-1-nitrosourea-induced mammary tumours with immunostimulatory CpG motifs and 13-cis retinoic acid in female rats: histopathological studyJan Liska, Danica Macejova, Stefan Galbavy, et al.
Vaccines|September 23, 2022
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in MiceSabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2012
Molecular and immunological characterization of Tri a 36, a low molecular weight glutenin, as a novel major wheat food allergenAlexandra Baar, Sandra Pahr, Claudia Constantin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunizationAngelika Stoecklinger, Ines Grieshuber, Sandra Scheiblhofer, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Vaccine|August 20, 2013
The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccineEsther E Weinberger, Almedina Isakovic, Sandra Scheiblhofer, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Strategies for the development of safe and effective DNA vaccines for allergy treatmentArnulf Hartl, Richard Weiss, Romana Hochreiter, et al.
The Journal of Allergy and Clinical Immunology|August 12, 2009
Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergensElisabeth Roesler, Richard Weiss, Esther E Weinberger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 14, 2012
Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: a novel tool for specific immunotherapyEsther E Weinberger, Martin Himly, Julia Myschik, et al.
International Archives of Allergy and Immunology|April 5, 2012
T cell epitopes of the timothy grass pollen allergen Phl p 5 of mice and men and the detection of allergen-specific T cells using Class II UltimersAngelika Stoecklinger, Sandra Scheiblhofer, Elisabeth Roesler, et al.
Allergy|December 28, 2019
Laser-facilitated epicutaneous immunotherapy with depigmented house dust mite extract alleviates allergic responses in a mouse model of allergic lung inflammationEvgeniia Korotchenko, Raquel Moya, Sandra Scheiblhofer, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|November 19, 2003
Treatment of 1-methyl-1-nitrosourea-induced mammary tumours with immunostimulatory CpG motifs and 13-cis retinoic acid in female rats: histopathological studyJan Liska, Danica Macejova, Stefan Galbavy, et al.
Vaccines|September 23, 2022
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in MiceSabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2012
Molecular and immunological characterization of Tri a 36, a low molecular weight glutenin, as a novel major wheat food allergenAlexandra Baar, Sandra Pahr, Claudia Constantin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunizationAngelika Stoecklinger, Ines Grieshuber, Sandra Scheiblhofer, et al.
Pageof 7